Almirall's Klisyri® (tirbanibulin) receives strong recommendation in American Academy of Dermatology AK guideline update

/PRNewswire/ -- Almirall, LLC, a global biopharmaceutical company focused on skin health, announced its microtubule inhibitor ointment, KLISYRI®...

Related Keywords

Miami ,Florida ,United States ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Spanish ,American ,Pablo Alvarez ,Brian Berman ,American Academy Of Dermatology Focused ,Prnewswire Almirall ,Spanish Stock Exchange ,University Of Miami Miller School Medicine ,Focused Update ,Professor Emeritus ,Miami Miller School ,Full Prescribing Information ,Actinic Keratosis ,Noble Purpose ,England Journal ,Almirall ,Lc ,